Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Return on Equity (2018 - 2025)

Serina Therapeutics' Return on Equity history spans 8 years, with the latest figure at 13.74% for Q3 2025.

  • For Q3 2025, Return on Equity fell 1403.0% year-over-year to 13.74%; the TTM value through Sep 2025 reached 13.74%, down 1403.0%, while the annual FY2024 figure was 1.11%, 100.0% up from the prior year.
  • Return on Equity for Q3 2025 was 13.74% at Serina Therapeutics, up from 13.93% in the prior quarter.
  • Across five years, Return on Equity topped out at 2.64% in Q4 2024 and bottomed at 20.25% in Q1 2025.
  • The 5-year median for Return on Equity is 0.12% (2021), against an average of 2.24%.
  • The largest annual shift saw Return on Equity skyrocketed 844bps in 2021 before it plummeted -2016bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.01% in 2021, then skyrocketed by 4328bps to 0.42% in 2022, then tumbled by -129bps to 0.12% in 2023, then surged by 2278bps to 2.64% in 2024, then tumbled by -621bps to 13.74% in 2025.
  • Per Business Quant, the three most recent readings for SER's Return on Equity are 13.74% (Q3 2025), 13.93% (Q2 2025), and 20.25% (Q1 2025).